Koonal Shah
Koonal Shah is an associate director and head of science policy at NICE. His project portfolio includes overseeing the NICE Listens deliberative public engagement programme, directing the process for making modular updates to NICE’s manuals, and contributing to NICE’s efforts to reduce the environmental impact of the health and care system. Koonal has a PhD in health economics and decision science from the University of Sheffield, an MSc (with distinction) in health economics from the University of York, and a BA in economics and philosophy from the University of Nottingham. He is an honorary senior research fellow at the Sheffield Centre for Health and Related Research, University of Sheffield.
Publications and Insights
- Publication: Meningococcal Vaccines: An International Comparison of Decision-Making Processes, Frameworks and Methodologies. Are Values Missing?
- Publication: Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead
- Publication: Valuing EQ-5D-Y Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?
- Publication: Public Preferences for Health Gains and Cures: A Discrete Choice Experiment
- Publication: Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology
- Publication: A New Valuation Method: Directly Eliciting Personal Utility Functions
- Publication: Age and Utilities: Issues for HTA
- Publication: Comparing the UK EQ-5D-3L and the English EQ-5D-5L Value Sets
- Publication: What is the Normative Basis for Selecting the Measure of ‘Average’ Preferences for Use in Social Choices?
- Publication: Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices?
- Publication: An Investigation of the Feasibility and Cultural Appropriateness of Stated Preference Methods to Generate EQ-5D-5L Values in the United Arab Emirates
- Publication: Exploring the Interdependencies of Research Funders in the UK
- Publication: The Expanding Value Footprint of Oncology Treatments
- Publication: Exploring the link between health and wealth in decision making
- Publication: Valuing Health at the End of Life: A Stated Preference Discrete Choice Experiment
- Publication: Valuing Health at the End of Life: An Exploratory Preference Elicitation Study
- Publication: A Comparison of Alternative Variants of the Lead and Lag Time TTO
- Publication: Using QALYs in Cancer: Review of the Methodological Limitations
- Publication: The Publicly Funded Vaccines Market in the UK
- Publication: The Publicly Funded Vaccines Market in Australia
- Publication: Assessment and Appraisal of Oncology Medicines: NICE’s Approach and International HTA Experience